News of oxford

Covax delivery: 657,000 doses of AstraZeneca vaccine arrive in Argentina

26-05-2021 13:52 Argentina received an additional 657,600 doses of the AstraZeneca vaccine from Amsterdam via the World Health Organisation's Covax scheme on Wednesday, a timely arrival as deaths from Covid-19 surpassed 75,000 deaths.

Mexico to start exporting AstraZeneca vaccines to Latin America

25-05-2021 17:20 Mexico will shortly begin exporting AstraZeneca-Oxford coronavirus vaccines to other Latin American nations, with a shipment of 800,000 doses set to arrive in Argentina this weekend.

Brazilian states suspend AstraZeneca vaccine for pregnant women

11-05-2021 12:34 Various Brazilian states including Sao Paulo and Rio de Janeiro have suspended the immunisation of pregnant women with the AstraZeneca coronavirus vaccine, following the advice of the national health regulator after a death was reported.

Argentina offers to manufacture delayed AstraZeneca vaccines

07-05-2021 01:50 With delays on Mexican end of mass co-production, Argentina seeks to unblock production of AstraZeneca-Oxford shots, offering to manufacture the entire vaccine domestically.

Major EU nations halt AstraZeneca as WHO says it is safe

15-03-2021 22:00 EU's largest countries joined stream of states halting rollouts of AstraZeneca jabs over blood clot fears, as the World Health Organisation and Europe's medicines watchdog insisted it was safe to use.  

Fernández, López Obrador demand fairer access to Covid-19 vaccines

23-02-2021 16:49 Alberto Fernández and Andrés Manuel López Obrador call for fairer distribution of Covid-19 vaccines in Latin America and across the world, with both in agreement that rich nations are monopolising jabs.

Argentina approves AstraZeneca-Oxford Covid vaccine

30-12-2020 16:57 Hours after Britain did the same, Argentina authorises use of coronavirus vaccine developed by drug firm AstraZeneca and Oxford University.

Covid-19: As lab execs sell shares worth millions, questions arise

15-11-2020 09:25 Executives at several US laboratories developing Covid-19 vaccines have recently pocketed millions of dollars by selling shares in their companies – raising questions about the propriety of such a move in the midst of a global health crisis.

Swiss regulator looking at AstraZeneca-Oxford virus vaccine

06-10-2020 14:58 Swiss authorities said Tuesday they had begun assessing AstraZeneca and Oxford University's Covid-19 vaccine – the first such treatment submitted for authorisation in the country.

Oxford University and AstraZeneca resume coronavirus vaccine trial

13-09-2020 08:52 Trials of potential coronavirus vaccine officially restart, days after clincal trials were suspended following a reported side-effect in a UK patient.

More than 8,000 new virus cases for second straight day

22-08-2020 08:34 Health Ministry announces 8,159 new cases recorded on Friday – the second straight day that the amount cleared 8,000. Total number of infections to date now reaches 329,043.

Light from the city of dreaming spires

15-08-2020 10:08 It is no longer enough for governments to concentrate solely on trying to block the spread of the virus. They are also expected to keep the economy moving and to worry about the long-term effects the prolonged lockdowns are certain to have on people’s lives.

by James Neilson